ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis Patients Treated With ABR-215757 (Paquinimod)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01487551
Recruitment Status : Completed
First Posted : December 7, 2011
Last Update Posted : August 27, 2014
Sponsor:
Information provided by (Responsible Party):
Active Biotech AB

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2013
  Actual Study Completion Date : February 2013